Blueprint Medicines Corp - Common Stock, par value $0.001 per share (BPMC)

317 filings reported holding BPMC - Blueprint Medicines Corp - Common Stock, par value $0.001 per share as of Q2 2021.
Blueprint Medicines Corp - Common Stock, par value $0.001 per share (BPMC) has 273 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 53.8M shares of 62.5M outstanding shares and own 86.14% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (5.57M shares), BlackRock Inc. (5.19M shares), PRICE T ROWE ASSOCIATES INC /MD/ (4.26M shares), WELLINGTON MANAGEMENT GROUP LLP (2.02M shares), STATE STREET CORP (1.65M shares), TimesSquare Capital Management, LLC (1.58M shares), JPMORGAN CHASE & CO (1.57M shares), Casdin Capital, LLC (1.55M shares), ALLIANCEBERNSTEIN L.P. (1.4M shares), and CADIAN CAPITAL MANAGEMENT, LP (1.32M shares).
This table shows the top 273 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.